171 related articles for article (PubMed ID: 9635662)
1. Efficacy of inhaled prostanoids in experimental pulmonary hypertension.
Kleen M; Habler O; Hofstetter C; Pusch R; Mueller M; Welte M; Zwissler B
Crit Care Med; 1998 Jun; 26(6):1103-9. PubMed ID: 9635662
[TBL] [Abstract][Full Text] [Related]
2. Effects of inhaled versus intravenous vasodilators in experimental pulmonary hypertension.
Walmrath D; Schermuly R; Pilch J; Grimminger F; Seeger W
Eur Respir J; 1997 May; 10(5):1084-92. PubMed ID: 9163651
[TBL] [Abstract][Full Text] [Related]
3. Prostacyclin aerosol and inhaled nitric oxide fail to reverse pulmonary vasoconstriction induced by thromboxane analogue in dogs.
Welte M; Zwissler B; Habler O; Kleen M; Messmer K
Acta Physiol Scand; 1995 Jul; 154(3):395-405. PubMed ID: 7572237
[TBL] [Abstract][Full Text] [Related]
4. Effects of inhaled prostacyclin as compared with inhaled nitric oxide on right ventricular performance in hypoxic pulmonary vasoconstriction.
Zwissler B; Welte M; Messmer K
J Cardiothorac Vasc Anesth; 1995 Jun; 9(3):283-9. PubMed ID: 7669961
[TBL] [Abstract][Full Text] [Related]
5. Successful weaning from cardiopulmonary bypass with central venous prostaglandin E1 and left atrial norepinephrine infusion in patients with acute pulmonary hypertension.
Tritapepe L; Voci P; Cogliati AA; Pasotti E; Papalia U; Menichetti A
Crit Care Med; 1999 Oct; 27(10):2180-3. PubMed ID: 10548203
[TBL] [Abstract][Full Text] [Related]
6. Effects of inhaled nitric oxide on platelet-activating factor-induced pulmonary hypertension in dogs.
Yamada T; Yukioka H; Hayashi M; Asada A; Inoue M
Acta Anaesthesiol Scand; 1998 Mar; 42(3):358-68. PubMed ID: 9542566
[TBL] [Abstract][Full Text] [Related]
7. Low-dose systemic phosphodiesterase inhibitors amplify the pulmonary vasodilatory response to inhaled prostacyclin in experimental pulmonary hypertension.
Schermuly RT; Ghofrani HA; Enke B; Weissmann N; Grimminger F; Seeger W; Schudt C; Walmrath D
Am J Respir Crit Care Med; 1999 Nov; 160(5 Pt 1):1500-6. PubMed ID: 10556112
[TBL] [Abstract][Full Text] [Related]
8. Interaction of acetylcholine and endothelin-1 in the modulation of pulmonary arterial pressure.
Schmeck J; Konrad C; Schöffel S; Wendel-Wellner M; Gluth H; Koch T; Krafft P
Crit Care Med; 2000 Dec; 28(12):3869-75. PubMed ID: 11153628
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide inhalation: effects on the ovine neonatal pulmonary and systemic circulations.
DeMarco V; Skimming JW; Ellis TM; Cassin S
Reprod Fertil Dev; 1996; 8(3):431-8. PubMed ID: 8795107
[TBL] [Abstract][Full Text] [Related]
10. Prostacyclin and milrinone by aerosolization improve pulmonary hemodynamics in newborn lambs with experimental pulmonary hypertension.
Kumar VH; Swartz DD; Rashid N; Lakshminrusimha S; Ma C; Ryan RM; Morin FC
J Appl Physiol (1985); 2010 Sep; 109(3):677-84. PubMed ID: 20616229
[TBL] [Abstract][Full Text] [Related]
11. Additive effects of inhaled nitric oxide and intravenous milrinone in experimental pulmonary hypertension.
Deb B; Bradford K; Pearl RG
Crit Care Med; 2000 Mar; 28(3):795-9. PubMed ID: 10752832
[TBL] [Abstract][Full Text] [Related]
12. PGI2 aerosol versus nitric oxide for selective pulmonary vasodilation in hypoxic pulmonary vasoconstriction.
Welte M; Zwissler B; Habazettl H; Messmer K
Eur Surg Res; 1993; 25(5):329-40. PubMed ID: 8404993
[TBL] [Abstract][Full Text] [Related]
13. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside.
Kieler-Jensen N; Lundin S; Ricksten SE
J Heart Lung Transplant; 1995; 14(3):436-43. PubMed ID: 7654728
[TBL] [Abstract][Full Text] [Related]
14. [Are there pulmonary vascular or respiratory effects of prostaglandin vehicles (ethanol, glycine buffer) after intravenous infusion or inhalation?].
Bund M; Winterhalter M; Weilbach C; Piepenbrock S
Pneumologie; 2007 Nov; 61(11):721-4. PubMed ID: 17729206
[TBL] [Abstract][Full Text] [Related]
15. Effects of inhaled nitric oxide and nebulized prostacyclin on hypoxic pulmonary vasoconstriction in anesthetized sheep.
Booke M; Bradford DW; Hinder F; Harper D; Brauchle RW; Traber LD; Traber DL
Crit Care Med; 1996 Nov; 24(11):1841-8. PubMed ID: 8917035
[TBL] [Abstract][Full Text] [Related]
16. Subthreshold doses of specific phosphodiesterase type 3 and 4 inhibitors enhance the pulmonary vasodilatory response to nebulized prostacyclin with improvement in gas exchange.
Schermuly RT; Roehl A; Weissmann N; Ghofrani HA; Schudt C; Tenor H; Grimminger F; Seeger W; Walmrath D
J Pharmacol Exp Ther; 2000 Feb; 292(2):512-20. PubMed ID: 10640287
[TBL] [Abstract][Full Text] [Related]
17. Inhaled nitric oxide potentiates actions of adenosine but not of sodium nitroprusside in experimental pulmonary hypertension.
Patterson KW; Deb B; Kavanagh BP; Pearl RG
Pharmacology; 1999 May; 58(5):246-51. PubMed ID: 10087465
[TBL] [Abstract][Full Text] [Related]
18. Systemic and pulmonary hypertension after abrupt cessation of prostacyclin: role of thromboxane A2.
Cuiper LL; Price PV; Christman BW
J Appl Physiol (1985); 1996 Jan; 80(1):191-7. PubMed ID: 8847301
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary and systemic hemodynamic responses to intravenous prostacyclin in broilers.
Wideman RF; Chapman ME; Erf GF
Poult Sci; 2005 Mar; 84(3):442-53. PubMed ID: 15782913
[TBL] [Abstract][Full Text] [Related]
20. Hemodynamic profiles of prostaglandin E1, isoproterenol, prostacyclin, and nifedipine in experimental porcine pulmonary hypertension.
Prielipp RC; McLean R; Rosenthal MH; Pearl RG
Crit Care Med; 1991 Jan; 19(1):60-7. PubMed ID: 1986891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
